TdaP-Booster (tee-dee-ay-pee boo-ster)



Similar documents
The clinical studies have been performed in children, adolescents and adults, from 4 years up to 55 years of age.

IMPORTANT: PLEASE READ

Parents and Grandparents

JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets

IMIGRAN injection is also used for treatment of cluster headache. Before you use your IMIGRAN injection. When you must not use it

Whooping Cough Vaccine for Pregnant Women

NEW ZEALAND CONSUMER MEDICINE INFORMATION Arrow - Diazepam

used to treat inflammation, corneal injury and bacterial infections in the external part of the eye.

Before you use Enbrel. When you must not use it

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

Protecting your baby against meningitis and septicaemia

Tdap and MenC booster vaccines. Information for parents of children in First Year of second level school

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

New Zealand Consumer Medicine Information

There is no information on the use of this medicine in those below 12 years of age.

UBISTESIN 1:200,000 and UBISTESIN FORTE 1:100,000

Factsheet September Pertussis immunisation for pregnant women. Introduction

SUMMARY OF PRODUCT CHARACTERISTICS

INFANRIX PENTA Combined Diphtheria-Tetanus-acellular Pertussis (DTPa), Hepatitis B and Inactivated Poliovirus Vaccine

CONSUMER MEDICINE INFORMATION

Package leaflet: Information for the user

New Zealand Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.

Filgrastim 300 mcg in 0.5 ml and 480 mcg in 0.5 ml (prefilled syringes) and 300 mcg in 1 ml (vials) solution for injection

Pertussis (whooping cough) immunisation for pregnant women the safest way to protect yourself and your baby

There is no information on the use of this medicine in those below 12 years of age.

Pertussis (whooping cough) immunisation for pregnant women

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and Clotrimazole 1% w/w

Zomig Nasal Spray. Zolmitriptan 5 mg Nasal Spray Solution. CONSUMER MEDICINE INFORMATION

CONSUMER MEDICINE INFORMATION ARROW - ROXITHROMYCIN

Human Normal Immunoglobulin Solution for Intravenous Infusion.

FLIXONASE ALLERGY Non Drowsy Nasal Spray 24 hour Effective Relief and Prevention Available in 60 & 150 sprays

Is your family at risk for pertussis?

NEW ZEALAND CONSUMER MEDICINE INFORMATION. other allergens, possibly unidentified.

Testosterone propionate, phenylpropionate, isocaproate and decanoate. Please read this leaflet carefully before you start using SUSTANON 250.

EpiPen Adrenaline (Epinephrine) 300 µg/0.3 ml Auto-Injector

Salamol CFC-Free Inhaler

MEDICATION GUIDE STELARA

Package leaflet: Information for the patient. Entyvio 300 mg powder for concentrate for solution for infusion vedolizumab

Package Leaflet: Information for the user

2 months Diptheria; Tetanus; Whooping Cough; Hib & Polio 1st dose Pneumococcal Conjugate Vaccination

SERETIDE Fluticasone propionate/salmeterol xinafoate Consumer Medicine Information

FREQUENTLY ASKED QUESTIONS ABOUT PERTUSSIS (WHOOPING COUGH)

DULCOLAX Tablets and Suppositories Bisacodyl

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride

TdaPBooster. Tetanus, diphtheria and pertussis vaccination of children, adolescents and adults throughout life

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners

XARELTO (Za-REL-toe) rivaroxaban

MALARONE Tablets (250/100) MALARONE Junior Tablets (62.5/25) MALARONE (Atovaquone and Proguanil Hydrochloride)

This leaflet answers some common questions about ARROW - MELOXICAM.

1g cream or ointment contains 1 mg methylprednisolone aceponate.

XARELTO (Za REL toe) rivaroxaban

PACKAGE LEAFLET: INFORMATION FOR THE USER. STAMARIL, powder and solvent for suspension for injection in pre-filled syringe Yellow fever vaccine (Live)

Galvumet Vildagliptin/Metformin hydrochloride Consumer Medicine Information

CONSUMER MEDICINE INFORMATION

Immunisation. for babies just after their first birthday

MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)

2 P age. Babies from Birth to Age 2

Package leaflet: Information for the patient. Laxido Orange, powder for oral solution

N HUMAN Novo Nordisk Patient Information for Novolin N

Document Title: PCT Doc Ref.: Version No.: 1/2014. Local Doc Ref.:

Humulin (HU-mu-lin) R

SYNACTHEN i.m./i.v. tetracosactide hexaacetate

I B2.4. Design of the patient information leaflet for VariQuin

Vaccines for a Healthy Pregnancy

Why Pertussis matters..

Package leaflet : information for the user. Dilute Adrenaline/Epinephrine Injection 1:10,000 adrenaline (epinephrine) (as acid tartrate) 0.

2 What you need to know before you have Ampiclox

1 What Anapen is and what it is used for?

FAQs on Influenza A (H1N1-2009) Vaccine

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

Chapter 3. Immunity and how vaccines work

Whooping cough and pregnancy

Pre-school immunisations

MEDICATION GUIDE. ACTEMRA (AC-TEM-RA) (tocilizumab) Solution for Intravenous Infusion

ALBERTA IMMUNIZATION POLICY GUIDELINES

Immunization Healthcare Branch. Meningococcal Vaccination Program Questions and Answers. Prepared by

BOOSTRIX PRODUCT INFORMATION

Frequently asked questions about whooping cough (pertussis)

Rubifen SR 20 mg slow release tablets

APO-Tramadol SR Contains the active ingredient, tramadol (as tramadol hydrochloride)

MS Contin suspension Morphine sulfate (mor-fean sul-fate)

Multiple sclerosis disease-modifying drugs second line treatments

MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b)

MEDICATION GUIDE. These serious side effects are described below:

160S01105, Page 1 of 7. Human Hepatitis B Immunoglobulin, solution for intramuscular injection.

PACKAGE LEAFLET: INFORMATION FOR THE USER. ADRENALINE (TARTRATE) STEROP 1 mg/1 ml Solution for injection. Adrenaline (Levorenine, Epinephrine)

Package Leaflet: Information for the user

Sativex Cannabis sativa L. extracts (delta-9-tetrahydrocannabinol and cannabidiol) Oromucosal Spray 5.5 / 10 ml

New Zealand Consumer Medicine Information

swine flu vaccination:

BE SURE. BE SAFE. VACCINATE.

Early Access to Medicines Scheme Treatment protocol Information for patients

Read all of this leaflet carefully before you start taking this medicine

Hepatitis B and Meningococcal Vaccination Programs for Grade 7 Students

Vaccinations and Spina Bifida and Hydrocephalus

What Codeine Phosphate Tablets are used for

What is whooping cough. (pertussis)? Information and Prevention. Ocument dn

Perfalgan 10 mg/ml, solution for infusion

SYNACTHEN DEPOT i.m. (tetracosactide hexaacetate) 1 mg/ml Suspension for injection

Transcription:

New Zealand Consumer Medicine Information TdaP-Booster (tee-dee-ay-pee boo-ster) Tetanus, diphtheria and pertussis (acellular mono-component) vaccine (adsorbed, reduced antigen content) CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about TdaP-Booster. It does not contain all the available information. It does not take the place of talking to your doctor, nurse or pharmacist. All medicines, including vaccines, have risks and benefits. Your doctor has weighed the risks of you or your child (of four years or older) having TdaP-Booster against the benefits they expect it will have. If you have any concerns about this vaccine, talk to your doctor, nurse or pharmacist. Keep this leaflet. You might need to read it again. What TdaP-Booster is used for TdaP-Booster is a combination vaccine. It helps prevent three diseases, each caused by a different infection. The diseases are diphtheria tetanus and pertussis (whooping cough). These infections are serious and can be life-threatening. TdaP-Booster is used to revaccinate children ( 4 years of age), adolescents and adults who have previously received at least three doses of a vaccine for primary immunisation against diphtheria, tetanus and whooping cough. TdaP-Booster is not intended for primary immunisation against diphtheria, tetanus and whooping cough. TdaP-Booster is given as one additional dose (booster dose) with intervals according to national recommendations. How TdaP-Booster works TdaP-Booster works by getting your body to produce its own protection against the three types of bacteria (germs). The germs are those that cause three different and serious infections diphtheria tetanus and pertussis (whooping cough).

The vaccine does not contain live germs and cannot give you these illnesses. After you have TdaP-Booster, your body makes substances called antibodies. These antibodies fight the diphtheria, the tetanus and pertussis germs. When you come into contact with these germs, your body is usually ready to destroy them. Most people who receive the booster dose (suitable only if in the past they have had the full primary course against diphtheria, tetanus and pertussis) will produce enough antibodies to protect against the three diseases. However, as with all vaccines, 100% protection cannot be guaranteed. Before you are given TdaP-Booster When you or your child must not be given TdaP-Booster Do not give TdaP-Booster to a child under 4 years of age. Do not use TdaP-Booster if you or your child are allergic to the active substances, or any of the other ingredients listed at the end of this leaflet, or to formaldehyde that may be present in very small amount you are suffering from progressive neurological diseases you are ill with high fever you have experienced problems of the nervous system (ie disease of the brain) within 7 days after previous vaccination with a vaccine against pertussis (whooping cough) disease Do not use TdaP-Booster after the expiry date printed on the pack. Do not use TdaP-Booster if the packaging is torn or shows signs of tampering. If you are not sure whether you or your child should have TdaP-Booster, talk to your doctor, nurse or pharmacist. Before you or your child are given TdaP-Booster Tell your doctor if: your immune response is weakened or you received immunosuppressive medicine; you can still be vaccinated with TdaP-Booster but your immune response may be lowered you are suffering from an illness or are receiving medical treatment that increases the risk of bleeding you are treated with medicines which prevent formation of blood clots you have experienced one or more of the following side effects after previous pertussis vaccination: o fever (temperature >40 C) within 48 hours of vaccination not due to any other identified cause o for children: a child has had shock-like state or being unresponsive for a long period of time within 48 hours of vaccination persistent crying lasting more than 3 hours or more within 48 hours of vaccination convulsion with or without fever within 3 days of vaccination Tell your doctor if you have an infection or high temperature.

Your doctor may decide to delay vaccination until the illness has passed. A mild illness, such as a cold, is not usually a reason to delay vaccination. Vaccination is recommended for persons suffering from HIV infection. As for all vaccines, medical supervision and treatment should be available in case there is a severe allergic reaction. Tell your doctor or nurse if you or the person to be immunised are breastfeeding, pregnant or intend to become pregnant. Your doctor will discuss the possible risks and benefits of having TdaP-Booster during breastfeeding or pregnancy. Taking other medicines Tell your doctor, nurse or pharmacist if you are taking any other medicines, including any that you get without a prescription from your pharmacy, supermarket or health food shop. TdaP-Booster can be given at the same time as other vaccines without reducing the effect of TdaP-Booster at different injection sites. Having other vaccines Tell your doctor if you have had any vaccines in the last 4 weeks. Your doctor will advise you if TdaP-Booster is to be given with another vaccine. Your doctor and pharmacist may have more information on medicines and vaccines to be careful with or avoid during vaccination with TdaP-Booster. How TdaP-Booster is given TdaP-Booster is given by a trained health professional, as an injection into the muscle. How much is given and when One dose of 0.5 ml is given. Ask your doctor, nurse or pharmacist to answer any questions you may have. If you are given too much (overdose) Because each TdaP-Booster contains only one dose, overdosage is unlikely. If you think you or anyone else may have been given too much of this medicine consult your doctor immediately or telephone the Poisons Information entre (telephone 0800 POISON (0800 764 766) in New Zealand) for advice, or go to Accident and Emergency at your nearest hospital. Do this even if there are no signs of discomfort or poisoning. Urgent medical attention may be required. After having TdaP-Booster Things you must do Keep an updated record of your vaccinations or your child s vaccinations.

TdaP-Booster should not normally interfere with your ability to drive or operate machinery. Side effects Tell your doctor, nurse or pharmacist as soon as possible if you or your child feel unwell after having TdaP-Booster. All medicines, including vaccines, can have side effects. TdaP-Booster may have unwanted side effects in some people. Sometimes they are serious, most of the time they are not. You or your child may need medical treatment if you get some of the side effects. Ask your doctor, nurse or pharmacist to answer any questions you have. Tell your doctor, nurse or pharmacist if you notice any of the following and they worry you: reaction at the injection site such as temporary redness, pain, itching or swelling fever, general malaise, irritability pain in the muscles headache tiredness long lasting itching nodules (granuloma) or sterile abscess at the site of injection Allergic reaction: As with all vaccines given by injection, there is a very small risk of a severe allergic reaction. If any of the following happen, consult your doctor, nurse or pharmacist immediately, or go to Accident and Emergency at your nearest hospital. sudden signs of allergy such as rash, itching or hives on the skin, swelling of the face, lips, tongue or other parts of the body shortness of breath These are very serious side effects. If you or your child has them, you may have had a severe allergic reaction to TdaP-Booster. You or your child may need urgent medical attention or hospitalisation. This type of side effect mostly occurs within the first few hours of being given the vaccine. Other side effects not listed above might occur in some people. Tell your doctor, nurse or pharmacist if you notice anything that is making you or your child feel unwell. Do not be alarmed by this list of possible side effects. You or your child may not experience any of them. Storing TdaP-Booster TdaP-Booster is usually stored in the doctor s surgery or clinic, or at the pharmacy. However, if you need to store TdaP-Booster : Keep it where children cannot reach it. Keep it in the original pack until it is time for it to be given. Keep it in the refrigerator, between 2 C and 8 C. Do not freeze TdaP-Booster. Protect from light. Discard the vaccine if it has been frozen.

Product description What TdaP-Booster looks like TdaP-Booster is supplied as a single dose (0.5 ml) in a needle-less pre-filled glass syringe. The vaccine should appear as white and grey particles suspended in a colourless fluid. Ingredients Active ingredients: Diphtheria Toxoid, purified: 2 IU Tetanus Toxoid, purified: 20 IU Pertussis Toxoid, purified: 20 µg Other ingredients: Aluminium hydroxide Sodium chloride Sodium hydroxide Water for injection. TdaP-Booster does NOT contain: lactose sucrose gluten tartrazine or any other azo dyes latex preservatives. The manufacture of this product includes exposure to bovine derived materials. No evidence exists that any case of vcjd (considered to be the human form of bovine spongiform encephalitis) has resulted from the administration of any vaccine product. Manufacturer/Distributor Manufacturer TdaP-Booster is made in Denmark by: Statens Serum Institut 5 Artillerivej 2300 Copenhagen S Denmark Distributor TdaP-Booster is distributed in New Zealand by: biocsl (NZ) Ltd P O Box 62 590 Greenlane, Auckland 1546 NEW ZEALAND Ph: 0800 502 757 Date of preparation June 2015

TdaP-Booster is a trademark of Statens Serum Institut.